PUBLISHER: TechNavio | PRODUCT CODE: 2144579
PUBLISHER: TechNavio | PRODUCT CODE: 2144579
Global Stem Cell Therapy Market 2026-2030
The global stem cell therapy market is forecasted to grow by USD 25294.5 mn during 2025-2030, accelerating at a CAGR of 20.2% during the forecast period. The report on the global stem cell therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising chronic disease prevalence fuels regenerative demand, technological advancements in allogeneic off-the-shelf therapeutics, expanding strategic corporate alliances mobilize capital deployment.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 18.1% |
| CAGR | 20.2% |
| Incremental Value | $25294.5 mn |
Technavio's global stem cell therapy market is segmented as below:
By Application
- Cancer
- Musculoskeletal disorder
- CVD
- Others
By Type
- Allogeneic transplants
- Autologous transplants
By End-User
- Hospitals
- Specialty clinics
- ASCs
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the induced pluripotent stem cells shift platform paradigms as one of the prime reasons driving the global stem cell therapy market growth during the next few years. Also, ai integration optimizes cellular biomanufacturing and in vivo cell reprogramming emerges beyond ex vivo processing will lead to sizable demand in the market.
The report on the global stem cell therapy market covers the following areas:
- Global stem cell therapy market sizing
- Global stem cell therapy market forecast
- Global stem cell therapy market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global stem cell therapy market vendors that include Akron Biotechnology LLC, Athersys Inc., BioLife Solutions Inc., Brainstorm Cell Therapeutics Inc., Gamida Cell Ltd., Holostem Terapie Avanzate Srl, Hope Biosciences, JCR Pharmaceticals Co. Ltd., Mesoblast Ltd., Novartis AG, Orgenesis Inc., Pluri Inc., Regrow Biosciences Pvt Ltd., REPROCELL Inc., Speratum Bio, STEMCELL Technologies Inc., Stempeutics Research Pvt. Ltd., Takeda Pharmaceutical Ltd., Transcell Biologics Pvt. Ltd., Vertex Pharmaceuticals Inc.. Also, the global stem cell therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Stem Cell Therapy Market 2020 - 2024
- Historic Market Size - Data Table on Global Stem Cell Therapy Market 2020 - 2024 ($ million)
- 5.2 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.3 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.4 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global stem cell therapy market
- 6.2 Impact of geopolitical conflicts on global stem cell therapy market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Application
- 8.1 Market segments
- 8.2 Comparison by Application
- 8.3 Cancer - Market size and forecast 2025-2030
- 8.4 Musculoskeletal disorder - Market size and forecast 2025-2030
- 8.5 CVD - Market size and forecast 2025-2030
- 8.6 Others - Market size and forecast 2025-2030
- 8.7 Market opportunity by Application
- Market opportunity by Application ($ million)
9 Market Segmentation by Type
- 9.1 Market segments
- 9.2 Comparison by Type
- 9.3 Allogeneic transplants - Market size and forecast 2025-2030
- 9.4 Autologous transplants - Market size and forecast 2025-2030
- 9.5 Market opportunity by Type
- Market opportunity by Type ($ million)
10 Market Segmentation by End-user
- 10.1 Market segments
- 10.2 Comparison by End-user
- 10.3 Hospitals - Market size and forecast 2025-2030
- 10.4 Specialty clinics - Market size and forecast 2025-2030
- 10.5 ASCs - Market size and forecast 2025-2030
- 10.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 India - Market size and forecast 2025-2030
- 12.5.3 Japan - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 Colombia - Market size and forecast 2025-2030
- 12.6.7 South Africa - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Rising chronic disease prevalence fuels regenerative demand
- Technological advancements in allogeneic off-the-shelf therapeutics
- Expanding strategic corporate alliances mobilize capital deployment
- 13.2 Market challenges
- Complex autologous manufacturing bottlenecks squeeze operating margins
- Divergent global regulatory frameworks delay clinical progress
- Restrictive institutional reimbursement coverage limits patient adoption
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Induced pluripotent stem cells shift platform paradigms
- AI integration optimizes cellular biomanufacturing
- In vivo cell reprogramming emerges beyond ex vivo processing
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Akron Biotechnology LLC
- Akron Biotechnology LLC - Overview
- Akron Biotechnology LLC - Product / Service
- Akron Biotechnology LLC - Key offerings
- SWOT
- 15.5 BioLife Solutions Inc.
- BioLife Solutions Inc. - Overview
- BioLife Solutions Inc. - Product / Service
- BioLife Solutions Inc. - Key offerings
- SWOT
- 15.6 Gamida Cell Ltd.
- Gamida Cell Ltd. - Overview
- Gamida Cell Ltd. - Product / Service
- Gamida Cell Ltd. - Key offerings
- SWOT
- 15.7 Holostem Terapie Avanzate Srl
- Holostem Terapie Avanzate Srl - Overview
- Holostem Terapie Avanzate Srl - Product / Service
- Holostem Terapie Avanzate Srl - Key offerings
- SWOT
- 15.8 Hope Biosciences
- Hope Biosciences - Overview
- Hope Biosciences - Product / Service
- Hope Biosciences - Key offerings
- SWOT
- 15.9 JCR Pharmaceticals Co. Ltd.
- JCR Pharmaceticals Co. Ltd. - Overview
- JCR Pharmaceticals Co. Ltd. - Product / Service
- JCR Pharmaceticals Co. Ltd. - Key offerings
- SWOT
- 15.10 Mesoblast Ltd.
- Mesoblast Ltd. - Overview
- Mesoblast Ltd. - Product / Service
- Mesoblast Ltd. - Key offerings
- SWOT
- 15.11 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- 15.12 Regrow Biosciences Pvt Ltd.
- Regrow Biosciences Pvt Ltd. - Overview
- Regrow Biosciences Pvt Ltd. - Product / Service
- Regrow Biosciences Pvt Ltd. - Key offerings
- SWOT
- 15.13 REPROCELL Inc.
- REPROCELL Inc. - Overview
- REPROCELL Inc. - Product / Service
- REPROCELL Inc. - Key offerings
- SWOT
- 15.14 STEMCELL Technologies Inc.
- STEMCELL Technologies Inc. - Overview
- STEMCELL Technologies Inc. - Product / Service
- STEMCELL Technologies Inc. - Key offerings
- SWOT
- 15.15 Stempeutics Research Pvt. Ltd.
- Stempeutics Research Pvt. Ltd. - Overview
- Stempeutics Research Pvt. Ltd. - Product / Service
- Stempeutics Research Pvt. Ltd. - Key offerings
- SWOT
- 15.16 Takeda Pharmaceutical Ltd.
- Takeda Pharmaceutical Ltd. - Overview
- Takeda Pharmaceutical Ltd. - Business segments
- Takeda Pharmaceutical Ltd. - Key news
- Takeda Pharmaceutical Ltd. - Key offerings
- Takeda Pharmaceutical Ltd. - Segment focus
- SWOT
- 15.17 Transcell Biologics Pvt. Ltd.
- Transcell Biologics Pvt. Ltd. - Overview
- Transcell Biologics Pvt. Ltd. - Product / Service
- Transcell Biologics Pvt. Ltd. - Key offerings
- SWOT
- 15.18 Vertex Pharmaceuticals Inc.
- Vertex Pharmaceuticals Inc. - Overview
- Vertex Pharmaceuticals Inc. - Product / Service
- Vertex Pharmaceuticals Inc. - Key offerings
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
